These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2067414)

  • 21. Pharmacokinetics of orbifloxacin and its concentration in body fluids and in endometrial tissues of mares.
    Haines GR; Brown MP; Gronwall RR; Merritt KA; Baltzley LK
    Can J Vet Res; 2001 Jul; 65(3):181-7. PubMed ID: 11480524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils.
    Brzozowski T; Konturek PC; Kwiecien S; Konturek SJ; Pajdo R; Drozdowicz D; Ptak A; Pawlik M; Stachura J; Pawlik WW; Hahn EG
    J Physiol Pharmacol; 2003 Mar; 54(1):33-51. PubMed ID: 12674217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa.
    Linsalata M; Russo F; Berloco P; Caruso ML; Matteo GD; Cifone MG; Simone CD; Ierardi E; Di Leo A
    Helicobacter; 2004 Apr; 9(2):165-72. PubMed ID: 15068419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery.
    Barbour A; Schmidt S; Rout WR; Ben-David K; Burkhardt O; Derendorf H
    Int J Antimicrob Agents; 2009 Sep; 34(3):231-5. PubMed ID: 19411164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients.
    Kim JM; Kim JS; Kim N; Jung HC; Song IS
    J Antimicrob Chemother; 2005 Nov; 56(5):965-7. PubMed ID: 16159928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sucralfate counteracts the inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide.
    Slomiany A; Piotrowski J; Slomiany BL
    Scand J Gastroenterol Suppl; 1995; 210():77-81. PubMed ID: 8578214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
    Slomiany BL; Piotrowski J; Slomiany A
    Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Saliva and blood concentration of cefuroxime in patients undergoing maxillofacial surgery.
    Venetis G; Chatzika K; Pitsiou G; Kechagias N; Antoniades K; Kioumis IP
    J Oral Maxillofac Surg; 2012 Jun; 70(6):1398-403. PubMed ID: 22459228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide.
    Piotrowski J; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1993 Dec; 31(6):1051-8. PubMed ID: 7514919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The aggravatory effect of nicotine on Helicobacter pylori-induced gastric mucosa injury: role of asymmetric dimethylarginine.
    Zhang Z; Zou YY; Zhou Y; Zhou H; Li YJ
    J Clin Gastroenterol; 2009 Mar; 43(3):261-6. PubMed ID: 18936714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of chloroquine on the bioavailability of ciprofloxacin in humans.
    Ilo CE; Ilondu NA; Okwoli N; Brown SA; Elo-Ilo JC; Agbasi PU; Orisakwe OE
    Am J Ther; 2006; 13(5):432-5. PubMed ID: 16988539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro inhibition of Helicobacter pylori growth and adherence to gastric mucosal cells by Pycnogenol.
    Rohdewald P; Beil W
    Phytother Res; 2008 May; 22(5):685-8. PubMed ID: 18350522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children.
    Agudo S; Alarcón T; Cibrelus L; Urruzuno P; Martínez MJ; López-Brea M
    Rev Esp Quimioter; 2009 Jun; 22(2):88-92. PubMed ID: 19544100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Concentration of ciprofloxacin in bone tissue].
    Meissner A; Borner K
    Aktuelle Traumatol; 1993 Apr; 23(2):80-4. PubMed ID: 8098576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal and systemic antibody levels against Helicobacter pylori do not parallel gastric inflammatory changes.
    Luzza F; Maletta M; Imeneo M; Marcheggiano A; Biancone L; Pallone F
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):36-9. PubMed ID: 9615262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of active efflux in antibiotic - resistance of clinical isolates of Helicobacter pylori.
    Falsafi T; Ehsani A; Niknam V
    Indian J Med Microbiol; 2009; 27(4):335-40. PubMed ID: 19736403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
    Nakao K; Imoto I; Ikemura N; Shibata T; Takaji S; Taguchi Y; Misaki M; Yamauchi K; Yamazaki N
    Am J Gastroenterol; 1997 Jun; 92(6):1005-11. PubMed ID: 9177520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of cefuroxime in traumatic wound secretion and antibacterial activity under vacuum therapy.
    Bischoff M; Beck A; Frei P; Bischoff G
    J Chemother; 2010 Apr; 22(2):92-7. PubMed ID: 20435567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa.
    McNulty CA; Dent JC; Ford GA; Wilkinson SP
    J Antimicrob Chemother; 1988 Nov; 22(5):729-38. PubMed ID: 3209531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification and prediction of skin pharmacokinetics of amoxicillin and cefuroxime.
    Shukla C; Patel V; Juluru R; Stagni G
    Biopharm Drug Dispos; 2009 Sep; 30(6):281-93. PubMed ID: 19591230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.